Document is current
Any future updates will be listed below
-
Authors
Nasr, Patrik https://orcid.org/0000-0002-2928-4188
Iredahl, Fredrik https://orcid.org/0000-0002-4245-7565
Dahlström, Nils
Rådholm, Karin https://orcid.org/0000-0003-3120-0913
Henriksson, Pontus https://orcid.org/0000-0003-2482-7048
Cedersund, Gunnar
Dahlqvist Leinhard, Olof
Ebbers, Tino https://orcid.org/0000-0003-1395-8296
Alfredsson, Joakim
Carlhäll, Carl-Johan https://orcid.org/0000-0003-2198-9690
Lundberg, Peter https://orcid.org/0000-0001-8661-2232
Kechagias, Stergios https://orcid.org/0000-0001-7614-739X
Ekstedt, Mattias https://orcid.org/0000-0002-5590-8601
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03864510 at ClinicalTrials.govDocuments that mention this clinical trial
Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
https://doi.org/10.1186/s12876-021-01763-z
-
Funding
Funding for this research was provided by:
Region Östergötland (ALF Grants)
Gilead Foundation (Non-restricted Grant)
Diapharma (Non-restricted Grant)
Faculty of Medicine, Linköping University (Lion Research Grant)
Vetenskapsrådet (VR 2020-04826)
Linköping University
- License Information
-
More Information
Article History
Received: 19 February 2021
Accepted: 12 April 2021
First Online: 20 April 2021
Declarations
:
: All recruitment and attained written informed consent are conducted according to World Medical Association of Helsinki 2018. Data is collected in accordance with the applicable General Data Protection Regulation (EU) 2016/679 (GDPR) legislation, and in compliance with the International Conference of Harmonization—Good Clinical Practice (ICH-GCP) requirements []. The EPSONIP study was approved by the Regional Ethical Board 2018/176-31 and 2018/494-32 and is registered as a clinical trial (clinicaltrials.gov identifier NCT 03864510). A complementary amendment, titled EPSONIP—Sleep, has been approved by the Swedish Ethical Review Authority 2019-03854.
: Not applicable.
: The authors declare that they have no competing interests.
